{"id":36864,"date":"2021-11-04T15:59:40","date_gmt":"2021-11-04T15:59:40","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=36864"},"modified":"2021-11-04T16:09:04","modified_gmt":"2021-11-04T16:09:04","slug":"raphael-nudelman","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/raphael-nudelman\/","title":{"rendered":"Raphael Nudelman"},"content":{"rendered":"
\n\n\t

Raphael Nudelman, PhD, ERT<\/h2>\n

Senior Director Impurity Expert, R&D Operations at Teva Pharmaceuticals<\/h4>\n\t

Raphael has over 20 years of pharmaceutical industry experience. He has a Ph.D. in organic chemistry from the Weizmann Institute of Science in Israel, a post-doctorate at the US Air Force Research Lab in Aberdeen Proving Ground, Maryland, and another post-doctorate at Duke University Medical Center, North Carolina. In 2001 he joined a startup biotech company in Israel that performed rational drug design by molecular modeling, and in 2003 Raphael joined the Medicinal Chemistry department at Teva Pharmaceuticals.<\/p>\n

In 2010 he established the Chemical & Computational Toxicology group in Teva, which he headed until mid-2021. Raphael now holds the position of Senior Director Impurity Expert in the R&D Operations and Biosimilars department. Raphael’s main topics of expertise are impurity and excipient qualification in drug substances and drug products.<\/p>\n\t\t\t\t\t\t\t\"Raphael_Nudelman_Teva_BioTech_Pharma_Summit_2021_gallery\"\t\t\t\t\t\t\t\n

\n\tTitle: Extractables & Leachables Qualification in Pre-Filled Syringes\n\t<\/h3>\n\t

The presentation will focus on:<\/p>\n